Virpax Pharmaceuticals Inc (VRPX)
0.775
-0.02
(-3.12%)
USD |
NASDAQ |
May 17, 16:00
0.7928
+0.02
(+2.30%)
After-Hours: 20:00
Virpax Pharmaceuticals Total Liabilities (Quarterly): 4.344M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.344M |
| December 31, 2023 | 7.694M |
| September 30, 2023 | 6.533M |
| June 30, 2023 | 3.647M |
| March 31, 2023 | 3.294M |
| December 31, 2022 | 3.095M |
| September 30, 2022 | 4.208M |
| June 30, 2022 | 2.483M |
| Date | Value |
|---|---|
| March 31, 2022 | 2.187M |
| December 31, 2021 | 2.088M |
| September 30, 2021 | 1.812M |
| June 30, 2021 | 3.852M |
| March 31, 2021 | 3.662M |
| December 31, 2020 | 4.682M |
| September 30, 2020 | 4.297M |
| December 31, 2019 | 2.779M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.812M
Minimum
Sep 2021
7.694M
Maximum
Dec 2023
3.791M
Average
3.654M
Median
Total Liabilities (Quarterly) Benchmarks
| SINTX Technologies Inc | 7.635M |
| BioCryst Pharmaceuticals Inc | 944.06M |
| Bolt Biotherapeutics Inc | 38.73M |
| Scilex Holding Co | 281.03M |
| Coya Therapeutics Inc | 5.000M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.130M |
| Shareholders Equity (Quarterly) | -1.213M |